PeptideWiki
FDA ApprovedGLP-1 Receptor Agonist⚖️ Weight Management

Liraglutide

Also known as: Victoza · Saxenda

An FDA-approved once-daily GLP-1 receptor agonist for type 2 diabetes and weight management. Produces 5-8% average weight loss with established cardiovascular safety data.

What is Liraglutide? An FDA-approved once-daily GLP-1 receptor agonist for type 2 diabetes and weight management. Produces 5-8% average weight loss with established cardiovascular safety data.

How does Liraglutide work? Liraglutide is a 97% homologous GLP-1 analog with a fatty acid side chain that enables once-daily dosing. It activates GLP-1 receptors to slow gastric emptying and reduce appetite.

Benefits of Liraglutide: FDA-approved for weight management; Reduces appetite and caloric intake; 5-8% average weight reduction; Improved glycemic control; Cardiovascular safety established; Once-daily dosing

Liraglutide dosage: Start at 0.6mg/day, titrate weekly to target of 1.8mg or 3mg.

Liraglutide half-life: 13 hours

Research status: FDA Approved

Source: PeptideWiki — https://www.peptide-wiki.net/peptides/liraglutide

31 AAs
MW: 3,751 Da
t½: 13 hours
CAS: 204656-20-2

From

$48.00

1 vendor option

Shop with Discount

Mechanism of Action

Liraglutide is a 97% homologous GLP-1 analog with a fatty acid side chain that enables once-daily dosing. It activates GLP-1 receptors to slow gastric emptying and reduce appetite.

Benefits

  • FDA-approved for weight management
  • Reduces appetite and caloric intake
  • 5-8% average weight reduction
  • Improved glycemic control
  • Cardiovascular safety established
  • Once-daily dosing

Side Effects & Risks

  • Nausea (very common)
  • Diarrhea
  • Constipation
  • Vomiting
  • Injection site reactions
  • Potential gallbladder disease

Where to Buy Liraglutide

1 option across 1 vendor · Sorted cheapest first · All include direct product link

From

$48.00

Best Price$48.00/ 5mg
$9.60/mg
Modern AminosBudget-Friendly COA
injectable5mg vial direct product link
10% off code:BRE

All links are affiliate links — PeptideWiki earns a commission at no extra cost to you. Coupon codes apply at checkout. Prices and availability may change. Always verify COA before purchasing.

Storage & Reconstitution Guide

Storage Temperature

-20°C (lyophilized)

24 months (lyophilized), 28 days (reconstituted)

Reconstitution Solvent

Bacteriostatic water (BAC water)

Swirl gently — do not shake or vortex

Handling Notes

Protect lyophilized peptide from moisture and light. Once reconstituted, keep refrigerated. Discard if solution becomes cloudy or discolored. Use insulin syringe for precise dosing.

Step-by-Step Reconstitution

1

Gather supplies

BAC water, insulin syringe, alcohol swabs, vial

2

Disinfect tops

Swab rubber stoppers of both vials with alcohol

3

Draw BAC water

Pull desired mL of BAC water into syringe

4

Inject slowly

Inject BAC water down the side of the peptide vial, swirl gently to dissolve

Clinical Trials & Human Studies1 trial

🏥 Clinical TrialPhase 3

SCALE Obesity and Prediabetes: Liraglutide 3mg for Weight Management

Pi-Sunyer X, et al.·New England Journal of Medicine·2015· n=3,731·56 weeks

In 3,731 adults with obesity (without T2D), liraglutide 3mg produced mean weight loss of 8.4 kg (-8.0%) vs 2.8 kg (-2.6%) placebo at 56 weeks (p<0.001). 63.2% vs 27.1% achieved ≥5% loss.

Primary Outcome

Weight change at 56 weeks

p-value

<0.001

Placebo

-2.8 kg (-2.6%)

≥5% Responders

63.2% vs 27.1%

Liraglutide 3mg

-8.4 kg (-8.0%)

≥10% Responders

33.1% vs 10.6%

Molecular Structure

2D molecular structure of Liraglutide (CAS 204656-20-2), formula C172H265N43O51 — source: PubChem CID 16134956
CAS Number
204656-20-2
PubChem CID
16134956
Molecular Weight
3,751 Da
Mol. Formula
C172H265N43O51
Amino Acids
31-AA peptide
Wikipedia
View article

Research Protocol

Dose Range
0.6–3 mg
Frequency
Once daily subcutaneous injection
Cycle
Ongoing / chronic
Half-Life
13 hours
Routes
subcutaneous injection
Notes
Start at 0.6mg/day, titrate weekly to target of 1.8mg or 3mg.
Open Dosage Calculator →

Legal & Regulatory Status

Research StatusFDA Approved
WADA Status Not Listed
FDA Classification✅ FDA Approved
Originsynthetic

Sold for research purposes only. Not for human use. Laws vary by country.

External Resources

PW

PeptideWiki Research Team

Evidence-based research data sourced from PubMed and ClinicalTrials.gov · Last updated: February 25, 2026

Cite: PeptideWiki. “Liraglutide.” peptide-wiki.net/peptides/liraglutide. Accessed 2026.

Frequently Asked Questions About Liraglutide

What is Liraglutide?

An FDA-approved once-daily GLP-1 receptor agonist for type 2 diabetes and weight management. Produces 5-8% average weight loss with established cardiovascular safety data.

What are the benefits of Liraglutide?

FDA-approved for weight management

What are the benefits of Liraglutide?

Reduces appetite and caloric intake

What are the side effects of Liraglutide?

Nausea (very common)

What is the recommended dosage for Liraglutide?

Start at 0.6mg/day, titrate weekly to target of 1.8mg or 3mg.

How long should a Liraglutide cycle last?

Ongoing / chronic

More Weight Management Peptides

View all Weight Management peptides →